Guaifenesin D Tablet, Extended Release
Product Images NDC 51316-993

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 1 technical images submitted to the FDA as part of the official labeling for Guaifenesin D (NDC 51316-993). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Cvs Pharmacy, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Principal Display Panel (36 Tablet Blister Pack Carton)

Principal Display Panel (36 Tablet Blister Pack Carton)
This is the product information of an expectorant and nasal decongestant medicine in the form of extended-release tablets. The medication is intended to help loosen mucus, relieve nasal congestion due to the common cold, promote nasal and sinus drainage, and temporarily restore free breathing through the nose. It's a bi-layer tablet with an immediate-release and an extended-release layer. The active ingredients are guaifenesin and pseudoephedrine HCI. The product should not be used by people having certain medical conditions, including high blood pressure, heart disease, thyroid disease, and diabetes. It also contains information on dosage, storage, possible side effects, and inactive ingredients. The product is not affiliated with the makers or owners of Mucinex®.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.